Cargando…
A deep learning-based model (DeepMPM) to help predict survival in patients with malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare disease with limited treatment and poor prognosis, and a precise and reliable means to predicting MPM remains lacking for clinical use. METHODS: In the population-based cohort study, we collected clinical characteristics from the Surveillanc...
Autores principales: | Li, Wei, Zhang, Minghang, Cai, Siyu, Li, Siqi, Yang, Biao, Zhou, Shijie, Pan, Yuanming, Xu, Shaofa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643950/ https://www.ncbi.nlm.nih.gov/pubmed/37969363 http://dx.doi.org/10.21037/tcr-23-422 |
Ejemplares similares
-
DeepMPM: a mortality risk prediction model using longitudinal EHR data
por: Yang, Fan, et al.
Publicado: (2022) -
Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax
por: Kuramochi, Masami, et al.
Publicado: (2023) -
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
por: Gounant, Valérie, et al.
Publicado: (2021) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
por: Klampatsa, Astero, et al.
Publicado: (2017) -
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
por: Pagano, Maria, et al.
Publicado: (2020)